# University College, London: Phase 3 study started recruiting, 784 planned (Tuberculosis (TB))

**Score:** 85/100

| Field | Value |
|---|---|
| Sponsor | University College, London |
| Sponsor type | Academic and hospital |
| Study | Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial) |
| NCT ID | NCT07163143 |
| Phase | Phase 3 |
| Status | recruiting |
| Conditions | Tuberculosis (TB) |
| Intervention types | drug |
| Target enrollment | 784 |
| Site countries | Pakistan, South Africa, Zimbabwe |
| Posted | 2025-09-09 |
| Planned start | 2026-10-12 |
| Event | Started recruiting |
| Event date | 2026-10-12 |
| Last update posted | 2026-10-26 |

## Why this score
- Posted in the last two weeks.
- Just started recruiting: sites, recruitment and supply are active.
- Phase 3: multi-site, larger budget.
- 784 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07163143). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.